Spero Therapeutics, Inc. (SPRO)
2.33
+0.06
(+2.64%)
USD |
NASDAQ |
Dec 31, 16:00
2.32
-0.01
(-0.43%)
After-Hours: 20:00
Spero Therapeutics Free Cash Flow: -27.67M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| BioMarin Pharmaceutical, Inc. | 825.79M |
| Amicus Therapeutics, Inc. | 9.691M |
| Cassava Sciences, Inc. | -83.91M |
| Omeros Corp. | -105.32M |
| GeoVax Labs, Inc. | -24.29M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 17.42M |
| Free Cash Flow Per Share (Quarterly) | 0.3096 |
| Free Cash Flow to Equity (Quarterly) | 17.69M |
| Free Cash Flow to Firm (Quarterly) | 17.42M |
| Free Cash Flow Yield | -21.38% |